PRTCY — PureTech Health plc

—
OTC · Health Care · Pharmaceuticals · CIK 1782999 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2026-09-22

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — 637,278,000 121,275,000 257,789,000
Dec 2025 — — — — 534,710,000 252,470,000 229,034,000
Jun 2025 — — — — 553,242,000 260,604,000 184,217,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-77,231,000
Inventory
—
Receivables
—
ST Investments
$24,829,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$6,365,000
EBITDA
$-101,248,000
Free Cash Flow
$-94,309,000
Enterprise Value
$330,850,080
Total Cash
$231,518,000
Total Debt
$222,726,000
Shares Out
24,341,819
Trailing EPS
$0.00
Book Value
$15.87
ROE
0.4%
ROA
-10.8%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 4,659,000 -98,525,000 -109,739,000 534,710,000 229,034,000 312,073,000 -85,131,000
Dec 2024 4,315,000 -136,095,000 53,510,000 602,635,000 194,702,000 414,707,000 -134,369,000
Dec 2023 750,000 -146,201,000 -65,697,000 693,973,000 235,742,000 464,066,000 -105,917,000
Dec 2022 2,090,000 -197,806,000 -50,354,000 702,647,000 155,058,000 542,220,000 -178,792,000

Peers — same industry

TickerNameMarket CapLastDaily %
LLY ELI LILLY & Co $1.26T $1415.55 —
JNJ JOHNSON & JOHNSON $670.92B $278.70 —
ABBV AbbVie Inc. $517.59B $292.82 —
MRK Merck & Co., Inc. $353.44B $143.37 —
NVS NOVARTIS AG $302.46B $159.13 —

News headlines (Yahoo Finance, 1h cache)

PureTech Health gets Panmure Liberum ‘buy’ on value and cash returns
2026-10-07 14:00 · Yahoo
PureTech Health Wins 2026 Prix Galien USA Award in Incubators, Accelerators and Equity Category
2026-10-30 07:00 · Yahoo
PureTech Founded Entity Celea Therapeutics Appoints Paul Audhya, MD, MBA, as Chief Medical Officer
2026-10-29 11:01 · Yahoo
Celea Therapeutics Appoints Paul Audhya, MD, MBA, as Chief Medical Officer
2026-10-29 11:00 · Yahoo
PureTech Presents Phase 1b Results for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplastic Syndromes (HR-MDS) and Acute Myeloid Leukemia (AML) at ESMO 2026
2026-10-26 07:00 · Yahoo
PureTech Announces Presentation of Phase 1b Results for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplastic Syndromes (HR-MDS) and Acute Myeloid Leukemia (AML) at ESMO 2026
2026-10-19 06:00 · Yahoo
PureTech Founded Entity Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress
2026-10-09 17:00 · Yahoo
PureTech Founded Entity Seaport Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating GlyphAgo™ in Patients with Generalized Anxiety Disorder and Sleep Disturbance
2026-10-07 17:00 · Yahoo
Celea Therapeutics Presents SURPASS-IPF Phase 3 Trial Design and Statistical Considerations for Evaluating Clinical Trials in Idiopathic Pulmonary Fibrosis at the IPF Summit 2026
2026-09-30 11:00 · Yahoo
PureTech Health PLC (PTCHF) (H1 2026) Earnings Call Highlights: Cash Runway to 2028, Seaport's ...
2026-09-22 19:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.